Ph.D. Dinesh V Patel - 16 Jul 2025 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
President and CEO, Director
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Dinesh V. Patel, Ph.D.
Issuer symbol
PTGX
Transactions as of
16 Jul 2025
Net transactions value
$0
Form type
4
Filing time
18 Jul 2025, 16:01:15 UTC
Previous filing
17 Jun 2025
Next filing
23 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PATEL DINESH V PH D President and CEO, Director C/O PROTAGONIST THERAPEUTICS, INC., 7707 GATEWAY BLVD., SUITE 140, NEWARK /s/ Matthew Gosling, Attorney-in-Fact for Dinesh V. Patel, Ph.D. 18 Jul 2025 0001120477

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Gift $0 -5,000 -0.89% $0.000000 558,462 16 Jul 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 16, 2025, the Reporting Person made a charitable donation of 5,000 shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
F2 Includes an aggregate of 557 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 7, 2025.